Beyond the anti-obesity benefits of glucagon-like peptide-1 drugs

FHS
July 23, 2024
9:04 am

The advantages of glucagon-like peptide-1 (GLP-1) medicines beyond glycemic and weight control.

Legalization of cannabis is imminent, new premium partners enrich Anbau-Allianz, Cannovum’s cultivation alliance – Biotech Investments

EQS-News: Cannovum Cannabis AG / Key word(s): Alliance/Investment Cannovum Cannabis AG: Legalization of cannabis is imminent, new premium partners enrich Anbau-Allianz, Cannovum’s cultivation alliance 06.11.2023

November 7, 2023

Regeneron expects key Dupixent COPD data this year amid Eylea’s sales decline in the US

One of the drug industry’s best-selling therapies could be closer than expected to becoming the first biologic to treat COPD, or chronic obstructive pulmonary disease.

November 3, 2023

BIO-Europe 2023: Pharma balances on shaky financial and legislative footing – Pharmaceutical Technology

Share this article At the BIO-Europe conference, experts discussed barriers within the European pharmaceutical industry. Credit: GlobalData. Following a steady recovery from the Covid-19 pandemic

November 15, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.